Arrowhead's new President and Chief Executive Officer. On December 3, 2007, Dr. Anzalone was granted an option to purchase 2,000,000 shares of the common stock of Arrowhead at an exercise price of $3.92, the closing price of Arrowhead's shares on that date.
The pharmaceutical industry in India has made phenomenal progress in the past 10 years. With over $ 8 billion in domestic sales and another $ 5 billion in exports in the year 2006, both growing at double digit, it has acquired its place in the sun. It has also started making global footprints and over $ 2.5 billion worth of acquisitions were made overseas in past couple of years.
This evening at its premiere awards event, the KTEC PIPELINE announced Olga Koper, NanoScale Corporation, Manhattan, Kan., as the KTEC PIPELINE 'Innovator of the Year.' The 'Innovator of the Year' was chosen after a competition that included a refined business plan, a pitch to an expert panel and a score carried over from performance during the technology fellowship year.
Product sales for the quarter increased 25% over the prior-year quarter to $4.25 million from $3.40 million. Total revenue, consisting of product sales and contract research and development revenue, increased 23% to $4.77 million for the third quarter of fiscal 2008 from $3.86 million in the prior-year quarter. Net income for the third quarter of fiscal 2008 increased 62% to $1.70 million, or $0.36 per diluted share, compared to $1.05 million, or $0.22 per share, for the prior-year quarter.
Mass metrology innovators, Metryx, Limited, today announced the receipt of a multiple system follow-on order from Taiwanese semiconductor memory manufacturer, Inotera Memories, Inc. The order is for Metryx's Mentor DF3 platform and will be used initially to monitor etch applications.
BioForce Nanosciences Holdings, Inc., a producer of integrated biological and mechanical systems for life science researchers at the micro and nano scales, today announced that Kerry Frey, formerly President and Chief Operating Officer, will now be President and Chief Executive Officer. Eric Henderson, who was Chief Executive Officer, will now be Executive Vice President and Chief Science Officer, a newly created position.
mPhase/AlwaysReady, Inc., a micro and nanotechnology development company focused on advanced power and sensing solutions, today announced the completion of its 2008 strategic planning process, resulting in several new corporate developments that will accelerate the commercialization path of its revolutionary nanotechnology-based battery.
The money spent on printed and potentially printed electronics doubled in 2007, as did the number of organisations participating. There are now about 1500 organisations doing significant work, most of them being academic. In 2008, there will be much more emphasis on commercialisation and many more countries will join the fray.
Moscow State University and IBM announced details of an agreement to install a Blue Gene/P supercomputer at the Department of Computational Mathematics and Cybernetics. The new supercomputer, the first installation of the world famous Blue Gene computer in Russia, will be used for fundamental research in nanotechnology, new materials and life sciences.
pSivida Limited, a global drug delivery company, and Intrinsiq Materials Cayman Limited today announced that the assets of pSiNutria Limited, a wholly owned subsidiary of pSivida, has been sold to Intrinsiq Materials, a UK based venture capital backed company.